SeaStar Medical Holding Corporation WarrantICUCW
About: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Employees: 19
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 12 [Q4 2024] → 12 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.63% less ownership
Funds ownership: 32.36% [Q4 2024] → 31.73% (-0.63%) [Q1 2025]
11% less capital invested
Capital invested by funds: $500K [Q4 2024] → $445K (-$54.4K) [Q1 2025]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Research analyst outlook
We haven’t received any recent analyst ratings for ICUCW.
Financial journalist opinion
We haven’t received any recent news articles for ICUCW.